HTA Guidance: York University strikes again!
Does Health Technology Assessment guidance give adequate consideration to decisions about less costly and less effective alternatives?
A question that York University researchers strive to answer based on their knowledge of the National Institute for Health and Care Excellence (NICE) guidance and the use of Cost-effectiveness analyses in the threshold set by NICE to determine whether an intervention can deliver value for money.
Cost-effectiveness analysis (CEA) plays a key role informing decision-making in healthcare and, consequently, the interpretation of its results is discussed in formal guidance from health technology assessment (HTA) organisations.
To read the thought-provoking Research Paper from the University of York: click here.